
Thank you for your business, support and partnership in 2020! Medicilon appreciates working with you and
Read MoreThank you for your business, support and partnership in 2020! Medicilon appreciates working with you and
Read MoreJan 29th, 2021 – CDE announced that the innovative drug, 3D011-08 from 3D Medicines, was approved
Read MoreJan.27, 2021 – Xuanzhu Biotech announced that their XZP-5610, a new treatment for NASH (non-alcoholic steatohepatitis),
Read MoreRecently, Shanghai Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician and
Read MoreYou may say that the Coronavirus Pandemic will define 2020. You may say that 2020 has
Read MoreInflammatory immune diseases have gained much attention as the incidence has grown bigger each year. The
Read MoreDec.20, 2020, Hebei—The 13th China Pharmaceutical Strategy Conference 2020 was held successfully. The conference presented the
Read MoreMedicilon has constructed the GMP Drug Products Pilot Plant to meet the rising needs for innovative
Read MoreLet's Start the Conversation
Shanghai Medicilon Inc.
Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com